STESteris
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 10-K, Item 1
- Headquarters
- Dublin, L2
- CEO
- Daniel A. Carestio
- Next results
- around Feb 3, 2027
The biggest changes in the 10-K filed 2026-05-29, this fiscal year against the last, and the sentences in the MD&A (Item 7) where management explains them, quoted word for word. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.
Net income
+27.3% Big change FY to 2026-03-31 vs 2025-03-31“The fiscal 2026 effective tax rate from continuing operations increased when compared to 2025, primarily due to changes in geographic mix of income and unfavorable discrete items, including withholding taxes.”
Read it in the 10-K ↗
Operating margin
15.9% → 18.6% (+2.7 pts) Big change FY to 2026-03-31 vs 2025-03-31“The increase in operating income is primarily due to the benefits of higher volume, pricing, and productivity, which were partially offset by increased tariff costs and inflation.”
Read it in the 10-K ↗
“Operating margin declined as tariff costs and inflation more than offset the margin expansion otherwise driven by volume, pricing, and productivity.”
Read it in the 10-K ↗
Cash from operations
+16.8% Big change FY to 2026-03-31 vs 2025-03-31“The increase in cash flows from operations and free cash flow during the period was driven primarily by improvements in net income, which more than offset the significantly lower contribution from working capital when compared to the prior year.”
Read it in the 10-K ↗
“Net cash provided by operating activities increased in fiscal 2026 by 16.8% over fiscal 2025, and was driven primarily by improvements in net income, which more than offset the significantly lower contribution from working capital in fiscal 2026 compared with fiscal 2025.”
Read it in the 10-K ↗
Revenue
+8.7% FY to 2026-03-31 vs 2025-03-31“Service revenues for fiscal 2026 increased $287.9 million, or 11.1% over fiscal 2025, reflecting growth across all segments.”
Read it in the 10-K ↗
“Consumable revenues for fiscal 2026 increased $122.5 million, or 7.3%, over fiscal 2025, reflecting growth in the Healthcare and Life Sciences segments.”
Read it in the 10-K ↗
Gross margin
44.0% → 44.2% (+0.2 pts) FY to 2026-03-31 vs 2025-03-31The MD&A has no sentence that names a cause for this change. That can be worth a question: ask about the filing.
Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K ↗
Work on STE in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/STE/export.csv") into a cell.